Christine E. McLaren

8.2k citations

129 papers · 5.9k indexed · 3 hit papers · h-index 40

Hematology top 0.2%
Genetics top 0.2%
Nutrition and Dietetics top 0.2%
Molecular Biology top 10%
Oncology top 5%

Co-authors: Paul C. Adams Victor R. Gordeuk Gordon D. McLaren Frank L. Meyskens Wen‐Pin Chen James C. Barton Ronald T. Acton John H. Eckfeldt
Topics: Iron Metabolism and Disorders (60 papers)Hemoglobinopathies and Related Disorders (53 papers)Trace Elements in Health (23 papers)
Cited by: Hematology Genetics Nutrition and Dietetics
Journals: New England Journal of Medicine Proceedings of the National Academy of Sciences Journal of Clinical Oncology
Partner nations: United States Canada Australia

In The Last Decade

Christine E. McLaren

124 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hemochromatosis and Iron-Overload Screening in a Racially Diverse Population

2005 547 citations Paul C. Adams, David M. Reboussin et al. New England Journal of Medicine profile →
Iron-Overload–Related Disease inHFEHereditary Hemochromatosis

2008 494 citations Katrina J. Allen, Lyle C. Gurrin et al. New England Journal of Medicine profile →
Haemochromatosis

2018 251 citations Paul C. Adams, Christine E. McLaren et al. profile →

Peers

Countries citing papers authored by Christine E. McLaren

Since Specialization

Citations

This map shows the geographic impact of Christine E. McLaren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine E. McLaren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine E. McLaren more than expected).

Fields of papers citing papers by Christine E. McLaren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine E. McLaren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine E. McLaren. The network helps show where Christine E. McLaren may publish in the future.

Co-authorship network of co-authors of Christine E. McLaren

This figure shows the co-authorship network connecting the top 25 collaborators of Christine E. McLaren. A scholar is included among the top collaborators of Christine E. McLaren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine E. McLaren. Christine E. McLaren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phase IIa Clinical Biomarker Trial of Dietary Arginine Restriction and Aspirin in Colorectal Cancer Patients 2023 ·Cancers ·Jason A. Zell,Thomas H. Taylor,Gregory Albers,Joseph C. Carmichael,Christine E. McLaren,Lari Wenzel,Michael J. Stamos	4
2	A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass Index 2019 ·Cancer Prevention Research ·Jason A. Zell,Christine E. McLaren,Timothy R. Morgan,Michael J. Lawson,Sherif Rezk,Gregory Albers,Wen‐Pin Chen,Joseph C. Carmichael,(unknown),Ellen Richmond,Luz M. Rodriguez,Éva Szabó,Leslie G. Ford,Michaël Pollak,Frank L. Meyskens	23
3	A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial of Lovastatin for Various Endpoints of Melanoma Pathobiology 2014 ·Cancer Prevention Research ·Kenneth G. Linden,Sancy A. Leachman,Jonathan S. Zager,James G. Jakowatz,Jaye L. Viner,Christine E. McLaren,Ronald J. Barr,Philip M. Carpenter,Wen‐Pin Chen,Craig A. Elmets,Joseph A. Tangrea,(unknown),Alistair J. Cochran,Frank L. Meyskens	20
4	Correlation of endogenous hormonal levels, fibroglandular tissue volume and percent density measured using 3D MRI during one menstrual cycle 2013 ·Annals of Oncology ·Jonathan H. Chen,(unknown),Stephanie Chan,(unknown),Min‐Ying Su,Christine E. McLaren	14
5	Phase IIa Clinical Trial of Curcumin for the Prevention of Colorectal Neoplasia 2011 ·Cancer Prevention Research ·Robert E. Carroll,Richard V. Benya,D. Kim Turgeon,Shaiju K. Vareed,Malloree Neuman,Luz M. Rodriguez,Madhuri Kakarala,Philip M. Carpenter,Christine E. McLaren,Frank L. Meyskens,Dean E. Brenner	403
6	IRon overload screeNing tool (IRON): Development of a tool to guide screening in primary care 2011 ·American Journal of Hematology ·Arch G. Mainous,Vanessa A. Díaz,Charles J. Everett,(unknown),Mary Hulihan,Althea M. Grant,Christine E. McLaren,Gordon D. McLaren	7
7	Levels of Rectal Mucosal Polyamines and Prostaglandin E2 Predict Ability of DFMO and Sulindac to Prevent Colorectal Adenoma 2010 ·Gastroenterology ·Patricia A. Thompson,Betsy C. Wertheim,Jason A. Zell,Wen‐Pin Chen,Christine E. McLaren,Bonnie LaFleur,Frank L. Meyskens,Eugene W. Gerner	39
8	Healthcare Provider and Parent Behavior and Children’s Coping and Distress at Anesthesia Induction 2009 ·Anesthesiology ·Jill Chorney,Carrie L. Torrey,Ronald L. Blount,Christine E. McLaren,Wen‐Pin Chen,Zeev N. Kain	43
9	HFE C282Y homozygotes are at increased risk of breast and colorectal cancer† 2009 ·Hepatology ·Nicholas J. Osborne,Lyle C. Gurrin,Katrina J. Allen,Clare C. Constantine,Martin B. Delatycki,Christine E. McLaren,Dorota M. Gertig,Gregory J. Anderson,Melissa C. Southey,John K. Olynyk,Lawrie W. Powell,John L. Hopper,Graham G. Giles,Dallas R. English	106
10	Longitudinal Assessment of Air Conduction Audiograms in a Phase III Clinical Trial of Difluoromethylornithine and Sulindac for Prevention of Sporadic Colorectal Adenomas 2008 ·Cancer Prevention Research ·Christine E. McLaren,Sharon Fujikawa-Brooks,Wen‐Pin Chen,Daniel L. Gillen,Daniel Pelot,Eugene W. Gerner,Frank L. Meyskens	26
11	Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial 2008 ·Cancer Prevention Research ·Frank L. Meyskens,Christine E. McLaren,Daniel Pelot,Sharon Fujikawa-Brooks,Philip M. Carpenter,Ernest T. Hawk,Gary J. Kelloff,Michael J. Lawson,Jayashri Kidao,John A. McCracken,Gregory Albers,Dennis J. Ahnen,D. Kim Turgeon,Steven Goldschmid,Peter Lance,Curt H. Hagedorn,Daniel L. Gillen,Eugene W. Gerner	392
12	Iron-Overload–Related Disease inHFEHereditary Hemochromatosisbreakdown → 2008 ·New England Journal of Medicine ·Katrina J. Allen,Lyle C. Gurrin,Clare C. Constantine,Nicholas J. Osborne,Martin B. Delatycki,Amanda Nicoll,Christine E. McLaren,Melanie Bahlo,Amy Nisselle,Chris D. Vulpe,Gregory J. Anderson,Melissa C. Southey,Graham G. Giles,Dallas R. English,John L. Hopper,John K. Olynyk,Lawrie W. Powell,Dorota M. Gertig	494
13	The Natural History of Serum Iron Indices for HFE C282Y Homozygosity Associated With Hereditary Hemochromatosis 2008 ·Gastroenterology ·Lyle C. Gurrin,Nicholas J. Osborne,Clare C. Constantine,Christine E. McLaren,Dallas R. English,Dorota M. Gertig,Martin B. Delatycki,Melissa C. Southey,John L. Hopper,Graham G. Giles,Gregory J. Anderson,John K. Olynyk,(unknown),Katrina J. Allen	63
14	HFE C282Y Homozygotes Aged 25–29 Years at HEIRS Study Initial Screening 2007 ·Genetic Testing ·James C. Barton,Ronald T. Acton,Catherine Leiendecker‐Foster,Laura Lovato,Paul C. Adams,Gordon D. McLaren,John H. Eckfeldt,Christine E. McLaren,David M. Reboussin,Victor R. Gordeuk,Mark Speechley,Jacob A. Reiss,Richard D. Press,Fitzroy W. Dawkins	6
15	Health-related quality of life in a racially diverse population screened for hemochromatosis: results from the Hemochromatosis and Iron Overload Screening (HEIRS) study 2007 ·Genetics in Medicine ·Lari Wenzel,Roger T. Anderson,Diane C. Tucker,Shana L. Palla,Elizabeth J. Thomson,Mark Speechley,Helen Harrison,(unknown),(unknown),John H. Eckfeldt,Jacob A. Reiss,Charles Rivers,Ebony Bookman,Beverly M. Snively,Christine E. McLaren	7
16	Initial Screening Transferrin Saturation Values, Serum Ferritin Concentrations, and HFE Genotypes in Whites and Blacks in the Hemochromatosis and Iron Overload Screening Study 2005 ·Genetic Testing ·James C. Barton,Ronald T. Acton,Fitzroy W. Dawkins,Paul C. Adams,Laura Lovato,C Leiendecker‐Foster,Christine E. McLaren,David M. Reboussin,Mark Speechley,Victor R. Gordeuk,Gordon D. McLaren,Phyliss Sholinsky,Emily Harris	59
17	Chemoprevention of Nonmelanoma Skin Cancer: Experience with a Polyphenol from Green Tea 2003 ·Recent results in cancer research ·Kenneth G. Linden,Philip M. Carpenter,Christine E. McLaren,Ronald J. Barr,(unknown),(unknown),(unknown),Jaye L. Viner,Frank L. Meyskens	26
18	African iron overload and hepatocellular carcinoma (HA‐7–0–080) 1998 ·European Journal Of Haematology ·Victor Moyo,(unknown),Innocent T. Gangaidzo,Victor R. Gordeuk,Christine E. McLaren,Hlosukwazi Khumalo,(unknown),Tracey A. Rouault,(unknown)	40
19	Effect of iron chelation therapy on mortality in Zambian children with cerebral malaria 1998 ·Transactions of the Royal Society of Tropical Medicine and Hygiene ·Philip E. Thuma,George F. Mabeza,Godfrey Biemba,Ganapati Bhat,Christine E. McLaren,Victor Moyo,(unknown),Hlosukwazi Khumalo,(unknown),(unknown),Dean Parry,(unknown),Gary M. Brittenham,Victor R. Gordeuk	62
20	Immediate diagnostic criteria for bacterial infection of ascitic fluid 1986 ·Gastroenterology ·(unknown),Arthur J. McCullough,Bruce R. Bacon,(unknown),(unknown),Christine E. McLaren,Satish C. Kalhan,Anthony S. Tavill	14

About Christine E. McLaren

Christine E. McLaren is a scholar working on Hematology, Genetics and Nutrition and Dietetics, having authored 129 papers that have together received 5.9k indexed citations. Recurring topics across this work include Iron Metabolism and Disorders (60 papers), Hemoglobinopathies and Related Disorders (53 papers) and Trace Elements in Health (23 papers). The work is most often cited by research in Hematology (2.6k citations), Genetics (2.3k citations) and Nutrition and Dietetics (1.6k citations). Christine E. McLaren has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Paul C. Adams, Victor R. Gordeuk, Gordon D. McLaren, Frank L. Meyskens, Wen‐Pin Chen, James C. Barton, Ronald T. Acton, John H. Eckfeldt, Mark Speechley and Philip M. Carpenter. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact